COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology

被引：69
|
作者：
White, Nicholas J. [1 ,2 ]
Watson, James A. [1 ,2 ]
Hoglund, Richard M. [1 ,2 ]
Chan, Xin Hui S. [1 ,2 ,3 ]
Cheah, Phaik Yeong [1 ,2 ]
Tarning, Joel [1 ,2 ]
机构：
[1] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand
[2] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England
[3] Univ Coll London Hosp NHS Fdn Trust, Hosp Trop Dis, London, England
来源：
PLOS MEDICINE | 2020年 / 17卷 / 09期
关键词：
SYSTEMIC-LUPUS-ERYTHEMATOSUS; POPULATION PHARMACOKINETICS; VIVAX MALARIA; DESETHYLCHLOROQUINE; DRUG; FALCIPARUM; BLOOD; TOXICITY; SAFETY; CHEMOPROPHYLAXIS;
D O I：
10.1371/journal.pmed.1003252
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Nicholas White and coauthors discuss chloroquine and hydroxychloroquine pharmacology in the context of possible treatment of SARS-CoV-2 infection.
引用
收藏
页数：24
相关论文
共 50 条
  • [1] COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology (vol 17, e1003252, 2020)
    [J]. PLOS MEDICINE, 2020, 17 (10)
  • [2] Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19
    Singh, Bhagteshwar
    Ryan, Hannah
    Kredo, Tamara
    Chaplin, Marty
    Fletcher, Tom
    [J]. EMERGENCIAS, 2022, 34 (04): : 305 - 307
  • [3] Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19
    Singh, Bhagteshwar
    Ryan, Hannah
    Kredo, Tamara
    Chaplin, Marty
    Fletcher, Tom
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (02):
  • [4] Evidence for Chloroquine/Hydroxychloroquine in the Treatment of COVID-19
    Shetty, Rajesh M.
    Namachivayam, ArunKumar
    [J]. INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2021, 25 (04) : 441 - 452
  • [5] Chloroquine and Hydroxychloroquine in Treatment of COVID-19 Disease
    Yildirim, Fatma
    [J]. JOURNAL OF CRITICAL & INTENSIVE CARE, 2020, 11 : 23 - 26
  • [6] Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
    Ho, Tzu-Chuan
    Wang, Yung-Hsuan
    Chen, Yi-Ling
    Tsai, Wan-Chi
    Lee, Che-Hsin
    Chuang, Kuo-Pin
    Chen, Yi-Ming Arthur
    Yuan, Cheng-Hui
    Ho, Sheng-Yow
    Yang, Ming-Hui
    Tyan, Yu-Chang
    [J]. PATHOGENS, 2021, 10 (02): : 1 - 9
  • [7] Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19
    Meo, S. A.
    Klonoff, D. C.
    Akram, J.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (08) : 4539 - 4547
  • [8] Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine
    Bakadia, Bianza Moise
    He, Feng
    Souho, Tiatou
    Lamboni, Lallepak
    Ullah, Muhammad Wajid
    Boni, Biaou Ode
    Ahmed, Abeer Ahmed Qaed
    Mukole, Biampata Mutu
    Yang, Guang
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2021, 133
  • [9] Chloroquine and hydroxychloroquine in covid-19
    Ferner, Robin E.
    Aronson, Jeffrey K.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2020, 369
  • [10] Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19
    Zou, Li
    Dai, Lijun
    Zhang, Xingyu
    Zhang, Zhaohui
    Zhang, Zhentao
    [J]. ARCHIVES OF PHARMACAL RESEARCH, 2020, 43 (08) : 765 - 772
12345